Interventional Cardiology Products Market by type - Global Forecast to 2022

Interventional Cardiology Products Market by type -
Global Forecast to 2022
The global Interventional Cardiology Products Market is expected to reach USD 20.85 Billion by
2022 from USD 14.52 Billion in 2017, at a CAGR of 7.5%. Market growth is primarily driven by
the growing incidence of CVD and technological advancements in interventional cardiology
devices.
The global Interventional Cardiology Products Market is segmented based on type and region.
By type, the global market is segmented into angioplasty balloons, angioplasty stents,
catheters, plaque modification devices, hemodynamic flow alteration devices, and other
devices. The angioplasty stents segment is estimated to account for the largest market of the
global market in 2017. Factors driving the growth of this segment include the widespread use of
stents.
Request for Sample @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=548
The plaque modification devices market is further classified into thrombectomy devices and
atherectomy devices. The thrombectomy devices segment is estimated to account for the
largest share of the global plaque modification devices market. The large share of this segment
can be attributed to the increasing demand for plaque removal procedures and rising
incidences of plaque deposition.
The other Interventional Cardiology Products Market is segmented into guidewires, vascular
closure devices, introducer sheaths, and balloon inflation devices. The guidewires segment is
estimated to account for the largest share of the global other market. Growth in the number of
interventional procedures and increasing use of guidewires in stenting procedures are the
major factors driving the growth of this segment.
The global Interventional Cardiology Products Market is dominated by North America, followed
by Europe. North America will continue to dominate the global market in the forecast period.
However, Asia Pacific is expected to witness the highest CAGR, with the growth in this market

centered on Japan, China, and India. Factors such as the rising focus of major players in
emerging Asia Pacific countries and government support are driving the growth of the
Interventional Cardiology Products Market in this region.
Major industry players launched innovative products to maintain and improve their position in
the interventional cardiology devices market. Medtronic (US), Boston Scientific (US), Abbott
Laboratories (US), Terumo (Japan), Cordis (US), B. Braun (Germany), C.R. Bard (US), Biosensors
(Singapore), and BIOTRONIK (Germany) have been identified as key players in this market.
To Know More @ https://www.marketsandmarkets.com/Market-Reports/minimally-invasiveinterventional-cardiology-devices-market-548.html